KD Logo

Acadia Pharmaceuticals Inc [ACAD] stock for 89,673 USD was sold by GAROFALO ELIZABETH A.

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Acadia Pharmaceuticals Inc shares valued at $89,673 were sold by GAROFALO ELIZABETH A. on Mar 05 ’25. At $18.23 per share, GAROFALO ELIZABETH A. sold 4,919 shares. The insider’s holdings dropped to 17,595 shares worth approximately $0.3 million following the completion of this transaction.

Also, GAROFALO ELIZABETH A. purchased 4,919 shares, netting a total of over 89,673 in proceeds.

Before that, Kihara James had sold 475 shares from its account. In a trade valued at $9,481, the PRINCIPAL ACCOUNTING OFFICER traded Acadia Pharmaceuticals Inc shares for $19.96 each. Upon closing the transaction, the insider’s holdings decreased to 475 shares, worth approximately $0.34 million.

As published in their initiating research note from Deutsche Bank on February 11, 2025, Acadia Pharmaceuticals Inc [ACAD] has been a Hold and the price target has been revised to $22. Analysts at Guggenheim downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in early January. Earlier on August 07, 2024, Morgan Stanley downgraded its rating. Their new recommendation was “an Equal-weight” for ACAD stock which previously was a “an Overweight”.

Analyzing ACAD Stock Performance

During the last five days, there has been a drop of approximately -4.71%. Over the course of the year, Acadia Pharmaceuticals Inc shares have dropped approximately -8.56%. Shares of the company reached a 52-week high of $20.68 on 02/21/25 and a 52-week low of $16.59 on 03/13/25. A 50-day SMA is recorded $18.39, while a 200-day SMA reached $16.76.

Support And Resistance Levels for Acadia Pharmaceuticals Inc (ACAD)

According to the 24-hour chart, there is a support level at 16.61, which, if violated, would cause prices to drop to 16.44. In the upper region, resistance lies at 16.93. The next price resistance is at 17.08. RSI (Relative Strength Index) is 33.13 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.23, which suggests the price will decrease in the coming days. Percent R is at 95.29%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.

Most Popular